1,050 results on '"Lilja H"'
Search Results
102. Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer
103. Une analyse des stratégies d'échantillonnage des réseaux de surveillance de la qualité des sols en Europe
104. 153 - Neoadjuvant hormonal therapies induce the expression of AR transcript variants
105. [46] Nuclear magnetic resonance studies of immobilized cells
106. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins
107. High birthweight and shoulder dystocia: the strongest risk factors for obstetrical brachial plexus palsy in a Swedish population-based study
108. [A new monitoring method for safer child delivery. Lower number of metabolic acidosis cases with fetal ECG and cardiotocography]
109. Lead time associated with screening for prostate cancer
110. 859 Evaluating the impact of adulthood metabolic disorders on prostatic cancer etiology with early-in-life risk factors
111. 848 18-year follow-up from the Gothenburg randomised prostate cancer screening trial
112. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study
113. Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence
114. Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step
115. Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semen
116. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing
117. Erratum: Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level (British Journal of Urology International 87 (638-642))
118. The New Old CD8+ T Cells in the Immune Paradox of Pregnancy
119. Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays
120. Characterization of the BRCA1-like immunoreactivity of human seminal plasma
121. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling
122. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
123. miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
124. 4 Men with total PSA levels between 1–2.99 ng/mL at initial screening have an elevated risk of future prostate cancer diagnosis: Results from the Gothenburg randomized screening trial
125. 1039 Genetic testing in identification of BPH patients developing later prostate cancer
126. 850 A prediction based on levels of four kallikrein markers in blood improves preoperative prediction of indolent versus
127. 858 Baseline PSA level in prediction of prostate cancer risk and aggressiveness: A Danish population-based cohort study
128. Integrated acoustic immunoaffinity-capture (IAI) platform for detection of PSA from whole blood samples
129. Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry
130. The Analytical Validation of Prostate Specific Mrna Detection in Whole Blood by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) as a Prognostic Biomarker for Patients with Castration-Resistant Prostate Cancer (CRPC)
131. Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function
132. Toward a rational strategy for prostate cancer screening based on long-term risk of prostate cancer metastases and death: Data from a large, unscreened, population-based cohort followed for up to 30 years.
133. Prognostic impact of post-prostatectomy PSA slope determined with a novel, nucleic acid detection immunoassay (NADiA ProsVue) for total PSA.
134. 26 RESULTS FROM THE GOTHENBURG RANDOMISED PROSTATE CANCER SCREENING TRIAL
135. The knowledge and practices of urologists in the United States (US) about standardization of PSA assays.
136. Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening
137. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study
138. Susceptibility loci associated with prostate cancer progression and mortality.
139. 878 DESIGN AND VALIDATION OF NOVEL TRANSGENIC MODELS OVER-EXPRESSING CATALYTIC OR NON-CATALYTIC PROSTATE-SPECIFIC ANTIGEN (PSA) IN THE MOUSE PROSTATE: ASSOCIATION WITH RELEASE OF PSA INTO BLOOD
140. Power spectral analysis of the fetal heart rate during noradrenaline infusion and acute hypoxemia in the chronic fetal lamb preparation
141. Early Versus Delayed Oxytocin Augmentation in Nulliparous Women With Prolonged Labor: A Randomized Controlled Trial
142. Three predominant prostatic proteins: Drei vorherrschende Prostataproteine
143. Cell biology of semenogelin: Zellbiologie von Semenogelin
144. 177 THE P-MARK BIOBANK: A EUROPEAN MULTICENTER BIOREPOSITORY FOR PROSTATE CANCER RESEARCH
145. 700 TOTAL HUMAN KALLIKREIN 2 - A POTENTIALLY USEFUL SERUM MARKER OF BONE METASTASIS AND BIOCHEMICAL FAILURE IN PROSTATE CANCER
146. 171 THE RISK OF BEING DIAGNOSED WITH POTENTIALLY INCURABLE PROSTATE CANCER IN MEN WITH PSA 1-3 NG/ML IS NOT RELATED TO THE RATIO OF FREE PSA
147. 289 CUMULATIVE INCIDENCE OF PROSTATE CANCER IN MEN PARTICIPATING IN A REPEATED PSA BASED SCREENING STUDY: RESULTS FROM THE GOTHENBURG BRANCH OF ERSPC
148. 293 RESULTS AFTER 7 SCREENING ROUNDS IN THE GOTHENBURG BRANCH OF ERSPC
149. Increase in percent free prostate-specific antigen in men with chronic kidney disease
150. Rapid elimination kinetics of free PSA and hK2 following initiation of GnRH-antagonist treatment of aggressive Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.